A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

Panelists discuss exciting phase 3 trial data on a novel selective phosphodiesterase inhibitor that elevates intracellular ...

With Baltimore's training camp fast approaching, we're looking at seven Ravens who'll need to elevate their games in 2025 for ...

Adults with overweight or obesity who received once-weekly ecnoglutide, a novel GLP-1 receptor agonist, had superior and ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

A new study suggests that intermittent fasting may reduce symptoms of depression by activating dopamine D1 receptors in the ...

Shane Wright, Assistant Professor at the Department of Physiology and Pharmacology, and colleagues have uncovered a new way ...

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

On May 29, 2025, Professor Sun Jinpeng's team and Professor Yu Xiao's team at Shandong University, collaborating with Professor Jiang Changtao from Peking University, Professor Pang Yanli, and ...

While emerging evidence suggests pesticides can be toxic to the mix of microorganisms in the digestive system, a new study is ...